The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
about
Natural selection of tumor variants in the generation of "tumor escape" phenotypesAdvances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)How I treat autoimmune lymphoproliferative syndromeUse of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Autoimmune lymphoproliferative syndrome: an update and review of the literatureThe naturally processed CD95L elicits a c-yes/calcium/PI3K-driven cell migration pathwayFAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndromeDecitabine and vorinostat cooperate to sensitize colon carcinoma cells to Fas ligand-induced apoptosis in vitro and tumor suppression in vivoNF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppressionAutoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosisCauses and consequences of the autoimmune lymphoproliferative syndromeGenome-wide association study identifies multiple risk loci for chronic lymphocytic leukemiaFrequent Fas gene mutations in testicular germ cell tumors.Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndromeAnalysis of Fas gene mutations on laser capture microdissected specimens from renal cell carcinoma.Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset.Rituximab responsive immune thrombocytopenic purpura in an adult with underlying autoimmune lymphoproliferative syndrome due to a splice-site mutation (IVS7+2 T>C) affecting the Fas gene.Extreme lymphoproliferative disease and fatal autoimmune thrombocytopenia in FasL and TRAIL double-deficient miceDiagnosis and management of autoimmune cytopenias in childhood.Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).Hodgkin lymphoma: an update on its biology with new insights into classification.ALPS-ten lessons from an international workshop on a genetic disease of apoptosisDevelopment of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease.Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.The power and the promise of restimulation-induced cell death in human immune diseases.Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds.The many roles of FAS receptor signaling in the immune systemNew advances in the diagnosis and treatment of autoimmune lymphoproliferative syndromeAutoimmune Lymphoproliferative Syndrome and Epstein-Barr Virus-Associated Lymphoma: An Adjunctive Diagnostic Role for Monitoring EBV Viremia?Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulationClues to immune tolerance: the monogenic autoimmune syndromesAutoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.Cytolytic pathways in haematopoietic stem-cell transplantation.Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy.Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome.Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets, and therapeutic tools.The expanding spectrum of the autoimmune lymphoproliferative syndromesThree coexisting lymphomas in one patient: genetically related or only a coincidence?Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes.H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.
P2860
Q24551158-A48F2D4D-40F1-4C97-AE0B-C78AED84A5D4Q24623371-2ED8F69A-5D48-4D46-AA2F-76AA81BA6496Q24633207-453806AA-5FBD-44E8-9181-7BF0C4E0EBB1Q24643047-BE3EAD1E-2183-4CC1-9783-350DF6B3EC32Q26825740-3C303E6C-1D6D-4478-807F-981EF6E0DA27Q27321306-26F262A6-3AFF-4B8D-B194-7B88BE1A4016Q28235519-2D9AA251-E6EA-412B-9847-43B2BD2000EEQ28263221-581F5ACE-297F-45D5-A915-5528CB3A97CCQ28268202-129828CB-9BE4-41B2-B627-22043BE0B4C1Q28299956-DDC40A2D-9DEF-4CAE-80CC-B6D7288EFE53Q28300792-DB48912A-C519-463E-95B8-23671DC5348BQ28943339-FD97B240-90E8-4297-8957-EE17CFFFEB0CQ30742274-B9C68D40-4853-41F6-A681-0472A2626EACQ30838565-02EF2EAE-C998-4021-ADD6-C38F77C3A0A0Q31119899-41B2FF46-9F1E-4E2D-837C-53E6DD0C11D2Q33375938-C0153D81-64C0-47B5-B577-0A4E363E265BQ33376403-C19F46D5-72DE-45C1-97A0-401507DF9632Q33388396-469EA8C6-F199-47A5-AC8B-FEBAA39E20ADQ33411497-B8F45F18-C63B-4F6D-8B5A-6A6990750E88Q33420245-20959D66-1AD6-4160-AB44-A59700A8AAF0Q33588862-BF8749C9-E5B1-42E6-AEC6-0194E24CBE33Q33807422-B6565190-348A-46BE-B2E1-4931846716BAQ33818169-644CC3B1-851B-49BA-B9A9-D653FD1499EDQ33944255-CC725D5D-1006-4CF2-8682-9A8817184E0DQ34009654-526F2F9C-CC4C-4694-A7B0-4604F218D2C4Q34166328-440F7D8D-3FA7-445E-8A02-293FE09F66C2Q34205697-CB352D24-69B3-49DB-928E-43AAE000CBEAQ34239719-E612341F-45C0-41D3-8C53-52F1A565CCECQ34393868-79845727-0A0A-49A2-8E19-06F6AFCFA9F3Q34428954-FADC8CAF-98B6-4D20-9DBF-F4131FC3FF1DQ34440616-280ADFB6-C3F5-4F07-BC62-3AB7201A531BQ34513178-5DD83B58-8250-4B35-A33A-F9F862A4D8C1Q34632083-706AC189-4A36-4085-98A0-48065842697BQ34698814-49003A6F-F2E7-4B10-8484-140F3F128259Q34809111-A60A3B33-5208-4CC5-9930-A93F065959D2Q35209364-5B49050C-C114-41D3-8190-568F599E8949Q35619447-ECDFA103-7E05-45CE-9672-054C36BD5810Q35770416-9F9D9437-2A7C-4148-B3CC-A5EE2FCB65CBQ35840445-D1D57AEB-CD28-4935-B878-120B6A2E58ABQ35931441-A08377D2-F8DB-489B-A12D-A26BC22FA3E3
P2860
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The development of lymphomas i ...... efective lymphocyte apoptosis.
@ast
The development of lymphomas i ...... efective lymphocyte apoptosis.
@en
type
label
The development of lymphomas i ...... efective lymphocyte apoptosis.
@ast
The development of lymphomas i ...... efective lymphocyte apoptosis.
@en
prefLabel
The development of lymphomas i ...... efective lymphocyte apoptosis.
@ast
The development of lymphomas i ...... efective lymphocyte apoptosis.
@en
P2093
P356
P1433
P1476
The development of lymphomas i ...... efective lymphocyte apoptosis.
@en
P2093
A K Vaishnaw
A M Peters
C E Jackson
C W Hallahan
P304
P356
10.1182/BLOOD.V98.1.194
P407
P577
2001-07-01T00:00:00Z